(Q90249925)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30513349%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

title

Glyco-engineered CHO cell lines producing alpha-1-antitrypsin and C1 esterase inhibitor with fully humanized N-glycosylation profiles (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30513349%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30513349%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

Johnny Arnsdorf

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30513349%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

Bjørn Voldborg

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30513349%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

Mikael Rørdam Andersen

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30513349%20AND%20SRC:MED&resulttype=core&format=json

Helene Faustrup Kildegaard

12 April 2020

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30513349%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

8

Gyun Min Lee

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30513349%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

author name string

Thomas Amann

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30513349%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

Anders Holmgaard Hansen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30513349%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

Henning Gram Hansen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30513349%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

Saranya Nallapareddy

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30513349%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

publication date

1 December 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30513349%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

published in

Metabolic Engineering

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30513349%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

volume

52

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30513349%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

page(s)

143-152

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30513349%20AND%20SRC:MED&resulttype=core&format=json

N-glycosylation and biological activity of recombinant human alpha1-antitrypsin expressed in a novel human neuronal cell line

12 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2018.11.014

Predictable tuning of protein expression in bacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2018.11.014

Recombinant human C1-inhibitor produced in Pichia pastoris has the same inhibitory capacity as plasma C1-inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2018.11.014

Proteolytic and N-glycan processing of human α1-antitrypsin expressed in Nicotiana benthamiana

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2018.11.014

Engineering selection stringency on expression vector for the production of recombinant human alpha1-antitrypsin using Chinese Hamster ovary cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2018.11.014

Emerging principles for the therapeutic exploitation of glycosylation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2018.11.014

Biochemical comparison of four commercially available C1 esterase inhibitor concentrates for treatment of hereditary angioedema

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2018.11.014

Transmission of hepatitis G virus in patients with angioedema treated with steam-heated plasma concentrates of C1 inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2018.11.014

One-step generation of triple knockout CHO cell lines using CRISPR/Cas9 and fluorescent enrichment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2018.11.014

Versatile microscale screening platform for improving recombinant protein productivity in Chinese hamster ovary cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2018.11.014

Case study on human α1-antitrypsin: Recombinant protein titers obtained by commercial ELISA kits are inaccurate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2018.11.014

Recombinant production of native human α-1-antitrypsin protein in the liver HepG2 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2018.11.014

The Immunoregulatory Roles of Antibody Glycosylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2018.11.014

Limitations to the development of humanized antibody producing Chinese hamster ovary cells using glutamine synthetase-mediated gene amplification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2018.11.014

Recombinant human alpha-1 proteinase inhibitor: towards therapeutic use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2018.11.014

Effect of glycosylation on the stability of alpha1-antitrypsin toward urea denaturation and thermal deactivation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2018.11.014

Expression of active human C1 inhibitor serpin domain in Escherichia coli.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2018.11.014

N-glycan analysis of human α1-antitrypsin produced in Chinese hamster ovary cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2018.11.014

Genomic landscapes of Chinese hamster ovary cell lines as revealed by the Cricetulus griseus draft genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2018.11.014

A versatile system for USER cloning-based assembly of expression vectors for mammalian cell engineering

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2018.11.014

Reduction in transmission of hepatitis C after the introduction of a heat-treatment step in the production of C1-inhibitor concentrate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2018.11.014

Glycosylation and secretion of human alpha-1-antitrypsin by yeast.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2018.11.014

Metabolism and metabolic burden by α1-antitrypsin production in human AGE1.HN cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2018.11.014

Reduction of ammonia and lactate through the coupling of glutamine synthetase selection and downregulation of lactate dehydrogenase-A in CHO cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2018.11.014

Comprehensive characterization of glutamine synthetase-mediated selection for the establishment of recombinant CHO cells producing monoclonal antibodies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2018.11.014

Using Titer and Titer Normalized to Confluence Are Complementary Strategies for Obtaining Chinese Hamster Ovary Cell Lines with High Volumetric Productivity of Etanercept

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2018.11.014

Accelerating genome editing in CHO cells using CRISPR Cas9 and CRISPy, a web-based target finding tool

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2018.11.014

Evidence for the transmission of parvovirus B19 in patients with bleeding disorders treated with plasma-derived factor concentrates in the era of nucleic acid test screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2018.11.014

Alpha1-antitrypsin deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2018.11.014

A phase I study of recombinant human C1 inhibitor in asymptomatic patients with hereditary angioedema

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2018.11.014

Expression of glycoproteins with excellent glycosylation profile and serum half-life in CAP-Go cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2018.11.014

Expression of C1 esterase inhibitor by the baculovirus expression vector system: preparation, purification, and characterization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2018.11.014

The genomic sequence of the Chinese hamster ovary (CHO)-K1 cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2018.11.014

Engineered CHO cells for production of diverse, homogeneous glycoproteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2018.11.014

Mammalian cell protein expression for biopharmaceutical production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2018.11.014

Commercialization of proteins produced in the mammary gland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2018.11.014

10.1016/J.YMBEN.2018.11.014

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30513349%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

1 reference